SpringWorks Therapeutics
NEWS
A roundup of last week’s top clinical trial announcements and news, including updates from Pfizer, BioNTech, Ocugen and more.
Mirati Therapeutics’ adagrasib is going up against Amgen’s Lumakras in the KRAS race, and according to Friday pre-market trading, the results shared Thursday don’t seem to be enough for investors.
Regeneron announced it has acquired Checkmate Pharmaceuticals and that it has entered a clinical trial collaboration with SpringWorks Therapeutics to treat multiple myeloma.
Heading out of November and into December, plenty of companies had clinical trial news to report. Here’s a look.
Yet another busy week for clinical trial news. Here’s a look.
SpringWorks has announced a research collaboration with the Dana-Farber Cancer Institute to advance its therapy development efforts for multiple myeloma and related diseases.
It was a busy week for clinical trial announcements. Take a look.
Biopharma and life science companies strengthen their leadership teams and boards with these Movers & Shakers.
It was another busy week of clinical trial announcements. Here’s a look.
JOBS
IN THE PRESS